Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $26

Benzinga Newsdesk www.benzinga.com Neutral 54.0%

Neg 0% Neu 54% Pos 0%

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $27 to $26.

Comments

No comments yet. Be the first!